Profusa (PFSA) Net Income towards Common Stockholders (2022 - 2026)
Profusa (PFSA) posted quarterly Net Income towards Common Stockholders of -$4.6 million for Q1 2026, down 311.28% year-over-year from $2.2 million in Q1 2025, and up 3.86% quarter-over-quarter from -$4.8 million in Q4 2025.
Profusa (PFSA) Net Income towards Common Stockholders (2022 - 2026) Analysis & Trends
Profusa's Net Income towards Common Stockholders history runs 5 years deep, the most recent figure standing at -$4.6 million for Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders fell 311.28% year-over-year to -$4.6 million; the TTM figure through Mar 2026 stood at -$40.2 million (down 345.56% YoY), while the FY2025 annual figure was -$70.7 million, down 711.45% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$4.6 million, up from -$4.8 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $1.4 million in Q3 2022, with the low at -$22.6 million in Q3 2025.
- The 5-year median for Net Income towards Common Stockholders is -$397487.0 (2024), against an average of -$2.8 million.
- The sharpest annual moves came in 2024 and 2025: Net Income towards Common Stockholders soared 129.48% in 2024, then sank 24839.79% in 2025.
- Profusa's Net Income towards Common Stockholders stood at -$902046.0 in 2022, then surged by 123.58% to $212692.0 in 2023, then slumped by 3666.2% to -$7.6 million in 2024, then surged by 36.84% to -$4.8 million in 2025, then advanced by 3.86% to -$4.6 million in 2026.
- Business Quant data shows PFSA's Net Income towards Common Stockholders at -$4.6 million in Q1 2026, -$4.8 million in Q4 2025, and -$22.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Profusa | 124,244.16 | -250,755.84 | - | -4.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.61 Mn |
| Dec 31, 2025 | -4.79 Mn |
| Sep 30, 2025 | -22.56 Mn |
| Jun 30, 2025 | -8.20 Mn |
| Mar 31, 2025 | -1.12 Mn |
| Dec 31, 2024 | -7.59 Mn |
| Sep 30, 2024 | 91,177.00 |
| Jun 30, 2024 | -397,487.00 |
| Mar 31, 2024 | -820,277.00 |
| Dec 31, 2023 | 212,692.00 |
| Sep 30, 2023 | -309,328.00 |
| Jun 30, 2023 | 134,623.00 |
| Mar 31, 2023 | 336,660.00 |
| Dec 31, 2022 | -902,046.00 |
| Sep 30, 2022 | 1.38 Mn |
| Jun 30, 2022 | 260,531.00 |
| Mar 31, 2022 | 797,050.00 |